Fluid Biomarkers Help Clinicians Differentiate Dementia Subtypes
Fluid biomarkers—measurable biological indicators in cerebrospinal fluid (CSF) and blood—have become essential tools for clinicians trying to distinguish...
Category Genetics
Biomarker Technology Advances Alzheimer’s Clinical Trial Design
Biomarker technology is fundamentally reshaping how Alzheimer's clinical trials are designed and executed.
Lessons From Multiple Neurodegenerative Diseases Advance Alzheimer’s Understanding
Decades of research into Parkinson's disease, Huntington's disease, multiple sclerosis, and other neurodegenerative conditions have yielded a powerful...
Next-Generation Assays Push Boundaries of Neurodegenerative Disease Detection
Next-generation assays are fundamentally changing how clinicians can detect neurodegenerative diseases, moving detection from late-stage symptoms to...
Down Syndrome Clinical Study Targets Alzheimer’s Risk Reduction
Yes. Vanderbilt University's ABATE clinical trial is actively testing an anti-amyloid beta vaccine specifically designed to reduce Alzheimer's risk in...
Sensitive Blood Tests Detect Alzheimer’s and Parkinson’s Biomarkers Earlier
Blood tests can now detect Alzheimer's disease and Parkinson's disease biomarkers years before symptoms appear, giving people and their doctors a critical...
Low-Dose Lithium May Protect Against Alzheimer’s Neurodegeneration
Recent research indicates that low-dose lithium may indeed protect against Alzheimer's neurodegeneration by addressing a fundamental deficit emerging in...
Down Syndrome Participants Join Landmark Alzheimer’s Risk Study
A man with Down syndrome in Tucker, Georgia has recently joined a landmark clinical trial aimed at reducing Alzheimer's disease risk, marking a...
Gene Variant Found Behind Majority of Alzheimer’s Cases
A single gene variant is responsible for between 72 and 93 percent of all Alzheimer's disease cases.
Nasal Tissue Samples Reveal Alzheimer’s Biomarkers Before Symptoms Appear
Yes, nasal tissue samples can reveal Alzheimer's disease biomarkers years before cognitive symptoms appear, according to recent research from the German...